Most critically, berberine is a strong inhibitor of several cytochrome P450 liver enzymes, specifically CYP3A4 and CYP2D6
L-5-MTHF is folate in its bioavailable form
This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available
Melanie Stein: I, I 100% agree
The HGF/c-Met pathway that Dihexa activates is also a known pro-cancer pathway, raising unresolved safety concerns
GLP-1 Microdosing Chart & Schedule According to a 2,700-person real-world study presented at the 2025 European Congress on Obesity, participants achieved an average 16% weight loss over 64 weeks at microdose levels of semaglutide: Microdosing GLP-1 Weight Loss Results Microdose GLP-1 yields 5-10% body weight loss in year one versus 15-20% with full-dose treatment plans